A Study of PF-07612577 in Healthy Adults
A Phase 1, Randomized, Double-Blind, Sponsor-Open, Placebo-Controlled, Single- and Multiple-Dose Study to Evaluate the Safety, Tolerability and Pharmacokinetics of PF-07612577 (PF-06264006 [CTB] and PF-07338233 [AVP]) in Healthy Adult Participants
Category & Conditions: Infections and Infectious Diseases
Medicine: PF-07612577 (Combination ceftibuten and avibactam)
ClinicalTrials.gov Identifier (NCT): NCT05554237
Protocol ID: C4691001
Open Plain Language Summary Result:
Click here